Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02864420
Other study ID # 2016P001337
Secondary ID
Status Completed
Phase N/A
First received August 3, 2016
Last updated July 7, 2017
Start date September 2016
Est. completion date December 2016

Study information

Verified date July 2017
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.


Description:

Hospitals are the standard of care for acute illness in the United States, but hospital care is expensive and often unsafe, especially for older individuals. While admitted, 20% suffer delirium, over 5% contract hospital-acquired infections, and most lose functional status that is never regained. Timely access to inpatient care is poor: many hospital wards are typically over 100% capacity, and emergency department waits can be protracted. Moreover, hospital care is increasingly costly: many internal medicine admissions have a negative margin (i.e., expenditures exceed hospital revenues) and incur patient debt.

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, 20% reduced cost, and 20% improved patient experience. While this is the standard of care in several developed countries, only 2 non-randomized demonstration projects have been conducted in the United States, each with highly local needs. Taken together, home hospital evidence is promising but falls short due to non-robust experimental design, failure to implement modern medical technology, and poor enlistment of community support.

The home hospital module offers most of the same medical components that are standard of care in an acute care hospital. The typical staff (medical doctor [MD], registered nurse [RN], case manager), diagnostics (blood tests, vital signs, telemetry, x-ray, and ultrasound), intravenous therapy, and oxygen/nebulizer therapy will all be available for home hospital. Optional deployment of food services, home health aide, physical therapist, occupational therapist, and social worker will be tailored to patient need. Home hospital improves upon the components of a typical ward's standard of care in several ways:

- Point of care blood diagnostics (results at the bedside in <5 minutes);

- Minimally invasive continuous vital signs, telemetry, activity tracking, and sleep tracking;

- On-demand 24/7 clinician video visits;

- 4 to 1 patient to MD ratio, compared to typical 16 to 1;

- Ambulatory/portable infusion pumps that can be worn on the hip;

- Optional access to a personal home health aide

Should a matter be emergent (that is, requiring in-person assistance in less than 20 minutes), then 9-1-1 will be called and the patient will be returned to the hospital immediately. In previous iterations of home hospital this happens in about 2% of patients.

Clinical parameters measured will be at the discretion of the physician and nurse, who treat the participant following evidence-based practice guidelines, just as in the usual care setting. In addition, the investigators will be tracking a wide variety of measures of quality and safety, including some measures tailored to each primary diagnosis.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Resides within 5-mile radius of emergency room

- English- or Spanish-speaker

- Can identify a potential caregiver who agrees to stay with patient for first 24 hours of admission. Caregiver must be competent to call care team if a problem is evident to her/him.

- This criterion may be waived for highly competent patients at the patient and clinician's discretion.

- >=18 years old

- Primary diagnosis of cellulitis, heart failure, complicated urinary tract infection, or pneumonia that requires inpatient admission as determined by blinded emergency room team.

Exclusion Criteria:

- Undomiciled

- No working heat (October-April), no working air conditioning if forecast > 80°F (June-September), or no running water

- On methadone requiring daily pickup of medication

- In police custody

- Resides in facility that provides on-site medical care (e.g., skilled nursing facility)

- Domestic violence screen positive

- Cared for by a private primary care physician who rounds in the hospital

- Cannot establish peripheral access in emergency department (or access requires ultrasound guidance)

- Secondary condition: active non-melanoma/prostate cancer, end-stage renal disease, acute myocardial infarction, acute cerebral vascular accident, acute hemorrhage

- Primary diagnosis requires narcotics for pain control

- Cannot independently ambulate to bedside commode

- As deemed by on-call medical doctor, patient likely to require any of the following procedures: computed tomography, magnetic resonance imaging, endoscopic procedure, blood transfusion, cardiac stress test, or surgery

- For pneumonia:

- Most recent CURB65 > 3: new confusion, blood urea nitrogen > 19mg/dL, respiratory rate>=30/min, systolic blood pressure<90mmHg, Age>=65

- Most recent SMRTCO > 2: systolic blood pressure < 90mmHg (2pts), multilobar chest xray involvement (1pt), respiratory rate >= 30/min, heart rate >= 125, new confusion, oxygen saturation <= 90%

- Absence of clear infiltrate on imaging

- Cavitary lesion on imaging

- O2 saturation < 90% despite 5L O2

- For heart failure:

- Has a left ventricular assist device or paced rhythm

- Get with the Guidelines - Heart Failure (>10% in-hospital mortality) or The Acute Decompensated Heart Failure National Registry score (high risk or intermediate risk 1)

- Anasarca

- Pulmonary hypertension

- For complicated urinary tract infection:

- Absence of pyuria

- Most recent quick sepsis related organ failure assessment > 1

- Home hospital census is full (maximum 4 patients at any time)

Study Design


Intervention

Other:
Home hospitalization

Inpatient Hospitalization


Locations

Country Name City State
United States Brigham and Women's Faulkner Hospital Boston Massachusetts
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (4)

Lead Sponsor Collaborator
Brigham and Women's Hospital Partners HealthCare, Smiths Medical, ASD, Inc., Vital Connect, Inc.

Country where clinical trial is conducted

United States, 

References & Publications (6)

Counsell SR, Holder CM, Liebenauer LL, Palmer RM, Fortinsky RH, Kresevic DM, Quinn LM, Allen KR, Covinsky KE, Landefeld CS. Effects of a multicomponent intervention on functional outcomes and process of care in hospitalized older patients: a randomized controlled trial of Acute Care for Elders (ACE) in a community hospital. J Am Geriatr Soc. 2000 Dec;48(12):1572-81. — View Citation

Cryer L, Shannon SB, Van Amsterdam M, Leff B. Costs for 'hospital at home' patients were 19 percent lower, with equal or better outcomes compared to similar inpatients. Health Aff (Millwood). 2012 Jun;31(6):1237-43. doi: 10.1377/hlthaff.2011.1132. — View Citation

Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009 Apr;5(4):210-20. doi: 10.1038/nrneurol.2009.24. Review. — View Citation

Hung WW, Ross JS, Farber J, Siu AL. Evaluation of the Mobile Acute Care of the Elderly (MACE) service. JAMA Intern Med. 2013 Jun 10;173(11):990-6. doi: 10.1001/jamainternmed.2013.478. — View Citation

Leff B, Burton L, Mader SL, Naughton B, Burl J, Inouye SK, Greenough WB 3rd, Guido S, Langston C, Frick KD, Steinwachs D, Burton JR. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med. 2005 Dec 6;143(11):798-808. — View Citation

Montalto M. The 500-bed hospital that isn't there: the Victorian Department of Health review of the Hospital in the Home program. Med J Aust. 2010 Nov 15;193(10):598-601. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Total cost of episode of care, $ Exploratory; Subset of sample for which claims data is available Day of admission to 30 days after discharge
Other Intraveneous medications, days Exploratory Day of admission to day of discharge
Other Intraveneous fluids, days Exploratory Day of admission to day of discharge
Other Intraveneous diuretics, days Exploratory Day of admission to day of discharge
Other Intraveneous antibiotics, days Exploratory Day of admission to day of discharge
Other Supplemental oxygen required, days Exploratory Day of admission to day of discharge
Other Nebulizer treatment, days Exploratory Day of admission to day of discharge
Other Medical Doctor sessions, # notes Exploratory Day of admission to day of discharge
Other Consultant sessions, # notes Exploratory Day of admission to day of discharge
Other Physical therapy/occupational therapy sessions, # notes Exploratory Day of admission to day of discharge
Other Primary care provider follow-up within 14 days, y/n Exploratory Day of discharge to 14 days later
Other Skilled nursing facility utilization, days Exploratory Day of discharge to 30 days later
Other Home health utilization, days Exploratory Day of discharge to 30 days later
Other Fall, y/n Exploratory Day of admission to day of discharge
Other Diagnosis of hospital-acquired or post-discharge deep vein thrombosis or pulmonary embolism Exploratory Day of admission to 30 days after discharge
Other Hospital-acquired pressure ulcer, y/n Exploratory Day of admission to day of discharge
Other Thrombophlebitis at peripheral intravenous site, y/n Exploratory Day of admission to day of discharge
Other Catheter-associated urinary tract infection, y/n Exploratory Day of admission to day of discharge
Other Clostridium difficile infection, y/n Exploratory Day of admission to day of discharge
Other Methicillin resistant staph aureus infection, y/n Exploratory Day of admission to day of discharge
Other Mortality during admission, y/n Exploratory Day of admission to day of discharge
Other Post-discharge mortality, y/n Exploratory Day of discharge to 30 days later
Other New arrhythmia, y/n Heart failure patients only; Exploratory Day of admission to day of discharge
Other Hypokalemia, y/n Heart failure patients only; Exploratory Day of admission to day of discharge
Other Acute kidney injury, y/n Heart failure patients only; Exploratory Day of admission to day of discharge
Other Mean Likert scale pain score, 0-10 Exploratory Day of admission to day of discharge
Other Pneumococcal vaccination if appropriate, y/n Pneumonia patients only; Exploratory Day of admission to day of discharge
Other Influenza vaccination if appropriate, y/n Pneumonia patients only; Exploratory Day of admission to day of discharge
Other Smoking cessation counseling if appropriate, y/n Pneumonia and heart failure patients only; Exploratory Day of admission to day of discharge
Other Evaluation of ejection fraction as assessed by echocardiogram or other appropriate study, scheduled or completed, if not done within 1 year; y/n Heart failure patients only; Exploratory; appropriate studies include cardiac magnetic resonance imaging, radionuclide ventriculography, single photon emission computed tomography myocardial perfusion imaging, or left ventriculography Day of admission to day of discharge
Other Angiotensin converting enzyme inhibitor or angiotensin receptor blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n Heart failure patients only; Exploratory Day of admission to day of discharge
Other Beta blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n Heart failure patients only; Exploratory Day of admission to day of discharge
Other Aldosterone antagonist for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n Heart failure patients only; Exploratory Day of admission to day of discharge
Other Lipid lowering for coronary artery disease, peripheral vascular disease, cerebrovascular accident, or diabetes, y/n Heart failure patients only; Exploratory Day of admission to day of discharge
Other Smoking status post-discharge Heart failure and pneumonia patients only; Exploratory; current/never/quit. 30 days after day of discharge
Other Use of inappropriate medications in the elderly, y/n Exploratory; using Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Beers criteria Day of admission to day of discharge
Other Use of Foley catheter, y/n Exploratory Day of admission to day of discharge
Other Use of restraints, y/n Exploratory Day of admission to day of discharge
Other >3 medications added to medication list, y/n Exploratory Day of discharge (compared with preadmission med list)
Other Patient health questionnaire-2, score Exploratory 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Other Patient-Reported Outcomes Measurement Information System Emotional Support Short Form 4a, score Exploratory 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Other Walk around ward/home, y/n Exploratory Day of discharge
Other Get to (non-commode) bathroom, y/n Exploratory Day of discharge
Other Walk 1 flight of stairs, y/n Exploratory Day of discharge
Other Visit with friends/family, y/n Exploratory Day of admission to day of discharge
Other Walk outside around my home, y/n Exploratory 30 days after discharge
Other Go shopping, y/n Exploratory 30 days after discharge
Other Time from admission decision to assessment by research assistant, minutes Exploratory Day of admission
Other Time from research assistant assessment to emergency department dismissal, minutes Exploratory Day of admission
Other Time from arrival home or to floor and medical doctor evaluation, minutes Exploratory Day of admission
Other Time from arrival home or to floor and registered nurse evaluation, minutes Exploratory Day of admission
Other Average Registered nurse to patient ratio Exploratory Day of admission to day of discharge
Other Number of registered nurse visits, total Exploratory Day of admission to day of discharge
Other Number of "on call" medical doctor interactions (video or phone), total Exploratory, intervention arm only Day of admission to day of discharge
Other Number of "on call" medical doctor in-person visits, total Exploratory, intervention arm only Day of admission to day of discharge
Other Duration of 1st registered nurse visit, minutes Exploratory, intervention arm only Day of admission
Other Average Duration of subsequent registered nurse visit, minutes Exploratory, intervention arm only Day of admission to day of discharge
Primary Total cost of hospitalization, $ Day of admission to day of discharge
Secondary Direct margin, $ Direct margin from total cost of hospitalization Day of admission to day of discharge
Secondary Direct margin, modeled with backfill, $ Backfill uses a model that estimates the cost of patients who take the place of home hospital patients Day of admission to day of discharge
Secondary Length of stay, days Day of admission to day of discharge
Secondary Imaging, # Day of admission to day of discharge
Secondary Lab Orders, # Day of admission to day of discharge
Secondary Discharge Disposition Routine, skilled nursing facility, home health, other Day of discharge
Secondary Readmission(s) after index hospitalization, y/n Dichotomous outcome Day of discharge to 30 days later
Secondary Time to readmission after index hospitalization, days Survival curve (hazard analysis) Day of discharge to 30 days later
Secondary Emergency Department (ED) observation stay(s) after index hospitalization, y/n Dichotomous outcome Day of discharge to 30 days later
Secondary Time to ED observation stay(s) after index hospitalization, days Survival curve (hazard analysis) Day of discharge to 30 days later
Secondary ED visit(s) after index hospitalization, y/n Dichotomous outcome Day of discharge to 30 days later
Secondary Time to ED visit(s) after index hospitalization, days Survival curve (hazard analysis) Day of discharge to 30 days later
Secondary Delirium, y/n Day of admission to day of discharge
Secondary Transfer back to hospital, y/n intervention arm only Day of admission to day of discharge
Secondary Hours of sleep, # Day of admission to day of discharge
Secondary Daily steps, # Day of admission to day of discharge
Secondary EuroQol -5D-5L, composite score At admission, at discharge, and at 30 days after discharge
Secondary Short Form 1 1-5 Likert scale 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Secondary Activities of daily living, score 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Secondary Instrumental activities of daily living, score 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
Secondary 3-item Care Transition Measure, score 30 days after discharge
Secondary Picker Experience Questionnaire, score 30 days after discharge
Secondary Global satisfaction with care, score 30 days after discharge
Secondary Qualitative interview 30 days after discharge
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy